Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Dr. Jeremy Faust, Paychex CEO & Cramer’s Outlook For Eli Lilly

Dr. Jeremy Faust, Paychex CEO & Cramer’s Outlook For Eli Lilly

FromMad Money w/ Jim Cramer


Dr. Jeremy Faust, Paychex CEO & Cramer’s Outlook For Eli Lilly

FromMad Money w/ Jim Cramer

ratings:
Length:
45 minutes
Released:
Dec 23, 2021
Format:
Podcast episode

Description

The Santa Claus rally continued today, with the Dow gaining 261 points, the S&P climbing 1.02%, and the NASDAQ jumping 1.18% and Jim Cramer is breaking down all the action. Next, as omicron spreads rapidly, emergency physician Dr. Jeremy Faust shares his plan that could help slow the spread. Plus, Cramer’s writing a prescription for Eli Lilly & digging into the buying opportunity the big pharma powerhouse provides. Then, what’s state of the labor market after the emergence of omicron? Cramer’s asking the head of one of the country’s biggest payroll processors, CEO of Paychex Marty Mucci. Finally, post-COVID, home is where the work is - Cramer has some stocks that could benefit from the continuing rise of the home office.
Released:
Dec 23, 2021
Format:
Podcast episode

Titles in the series (100)

"Mad Money w/ Jim Cramer", which airs weeknights at 6pm on CNBC, takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim is your personal guide through the confusing jungle of Wall Street investing, navigating through opportunities and pitfalls with one goal in mind - to help you make money. These full-length episodes feature the unmatched, fiery opinions of Jim Cramer and the popular "Lightning Round," in which Cramer gives his buy, sell, and hold opinions on stocks to callers....